
@AtlantisTrial results outlined in @NIHRevidence summary 👇 @alex_ford12399 @LeedsCTRU @ComplexCTRU @HazelEveritt @Dr_SarahA @riddmj @Robbie_Foy
This tweet is unavailable

This is the official Twitter account for the Complex Interventions Division within @leedsCTRU, led by Prof @Amanda_Horler

@AtlantisTrial results outlined in @NIHRevidence summary 👇 @alex_ford12399 @LeedsCTRU @ComplexCTRU @HazelEveritt @Dr_SarahA @riddmj @Robbie_Foy
This tweet is unavailable

We are so excited to be recruiting for Round 3 of our DTP. We have 38 amazing fully-funded projects at our 12 partner institutions listed here mrctmrpdtp.com/current-oppor… Please spread far and wide, closing date 15 Jan.

Interested in #LifeAfterStroke trials research #UKSF23 Please do get in contact with the LEAP team at @ComplexCTRU @LeedsCTRU Email contact 👇
@amanda_horler is a marvellous machine of a human! What a gargantuan effort presenting so much about the exciting proposed LEAP #platform #trial at #uksf23. With co-lead @audreybowenprof (also a marvellous machine), I'm honored to be a co-app and hope it gets funded! 🤞 #rehab

A great output from the @recreate_stroke team at the UK stroke form with some top tips from the RECREATE trial! #UKSF23
Our very own @JenAirlie and @Drjessjohansson doing a great job manning our poster detailing our reflections on conducting a large, pragmatic multicentre RCT in NHS stroke services at #UKSF23 @AUASResearch @ComplexCTRU

We are counting down to #UKSF23. The @recreate_stroke team are looking forward to seeing everyone there and presenting their reflections on conducting a large, pragmatic multicentre stroke rehabilitation cluster RCT in NHS stroke services! @UKStrokeForum @ComplexCTRU

Great to hear Amanda Farrin sharing plans to boost research during clinical care - more speed, less waste at UK Stroke Forum today! @ComplexCTRU @LeedsCTRU @UKStrokeForum @amanda_horler

Interested in platform trials for stroke survivors? Come to our session TODAY at the UK stroke forum #UKSF23 @LeedsCTRU 🌟
@ComplexCTRU team have arrived at #UKSF23 🥳 Join us tomorrow at our Fringe session at 3.40pm in Hall 7 to learn more about delivering platform trials for stroke survivors through collaboration

📢 Our @AtlantisTrial results demonstrating the benefits of amitriptyline for people with IBS are now published in the @TheLancet👇 @ComplexCTRU @LeedsCTRU
Delighted to see the @AtlantisTrial is published in this week’s issue of @TheLancet thelancet.com/journals/lance… In it, we report the effectiveness of amitriptyline as second-line treatment for #IBS in primary care @amanda_horler @HazelEveritt @Dr_SarahA @riddmj @Robbie_Foy

Lovely to see @AtlantisTrial highlighted in the week's summary of important papers by @TheLancet 👇👇 @LeedsCTRU @ComplexCTRU
Good to see @AtlantisTrial published in @TheLancet last week in the roundup of this weeks important articles in @bmj_latest. Thanks to collaborators incl. @amanda_horler @HazelEveritt @riddmj @Dr_SarahA @Robbie_Foy

Its now only 2 weeks until #UKSF2023! Looking forward to catching up with everyone and attending as many sessions as we can in what is a packed programme! 🤓 @UKStrokeForum @AUASResearch @ComplexCTRU
🚨 #UKSF23 Programme OFFICIAL!! 🚨 We are delighted to announce that the #UKSF23 programme is now available online. There are still one or two sessions that are currently TBC but we hope to finalise those shortly! For a full breakdown, please visit stroke.org.uk/professionals/…

Delighted to announce that the @AtlantisTrial of low-dose titrated amitriptyline as a second-line treatment for #IBS in primary care is now published online in @TheLancet authors.elsevier.com/sd/arti… I will be presenting the results today at 1430hrs at #UEGWeek2023

🚨Now published! 🚨The @AtlantisTrial showed benefits of amitriptyline in irritable bowel syndrome. Fantastic team work from all involved. Thank you to the participants and #teamGP for making it possible.
New online @TheLancet - Amitriptyline at Low-Dose and Titrated for #IBS as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial Catch the #UEGWeek presentation this pm by @alex_ford12399 thelancet.com/journals/lance…

Our ATLANTIS trial was clinical trial of the day this week: See a visualisation of the results below 👇
ATLANTIS trial: titrated low-dose #amitriptyline was superior to placebo as a second-line treatment for #IBS across multiple outcomes, and was safe and well tolerated bit.ly/3tByP66 #visualabstract #dataviz #gastrotwi #Gastroenterology @amanda_horler

New research led by Leeds, @unisouthampton, and @BristolUni has shown that amitriptyline, a cheap and widely available prescription drug, can improve symptoms of irritable bowel syndrome💊 IBS affects around 1 in 20 people worldwide🌍

📣 Read all about it Our @AtlantisTrial results are published today demonstrating the benefits of amitriptyline in improving the symptoms of #IBS Thank you to all who contributed to deliver this important trial @ComplexCTRU @alex_ford12399 @Dr_SarahA @HazelEveritt @riddmj
New online @TheLancet - Amitriptyline at Low-Dose and Titrated for #IBS as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial Catch the #UEGWeek presentation this pm by @alex_ford12399 thelancet.com/journals/lance…

** One Week Left ** Places are filling up for the upcoming Leeds CTRU CPD-certified course: “A Masterclass in the Design and Conduct of Complex Intervention Evaluations” But there is still time to sign up before the close of registration on Friday 8th September!